OrthoPediatrics (KIDS) reported a Q4 adjusted loss of $0.29 per diluted share, widening from the loss of $0.22 a year earlier.

Four analysts polled by FactSet expected a loss of $0.29.

Net revenue in the three months ended Dec. 31 rose to $52.7 million from $37.6 million a year ago.

Analysts surveyed by FactSet expected $51.3 million.

The company expects 2025 revenue of $235 million to $242 million. Analysts polled by FactSet project $239.8 million.